Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications
about
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.The use of natural health products by paediatric patients in respite care.Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software.Parkinson's disease between internal medicine and neurologyOpportunistic Screening of Vitamin B12 Deficiency in IT Professionals Presenting for Routine Health Check-up.Intestinal calcium and bile salts facilitate germination of Clostridium difficile spores.Proton-pump inhibitor therapy and vitamin B12 status in an inpatient hospital setting.Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review.Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.Loss of stomach, loss of appetite? Sequencing of the ballan wrasse (Labrus bergylta) genome and intestinal transcriptomic profiling illuminate the evolution of loss of stomach function in fish.Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months.Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients.Effects of Multivitamin and Multimineral Supplementation on Blood Pressure: A Meta-Analysis of 12 Randomized Controlled TrialsProton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
P2860
Q33767571-65C9C10E-A1EB-4EE1-8BFD-241DF54FAE98Q35099144-83486BFF-4935-48E4-8043-933924841B92Q36417202-DD6FF43A-57BC-48A5-A360-9AE656169AA1Q36464243-1574029D-40F8-44D0-91E2-D6164657C44CQ36476597-628BB48F-996F-4CD4-8D5B-8A8951B03255Q38680848-A7D6FEE2-7EF1-4068-94F7-3935C7448E8AQ38969006-8F7877DF-A5DA-44D0-8737-98FB1EEC88B0Q38995773-64CA0F23-3AF2-4A93-8F12-0233C196088FQ40087909-4DEB13CF-0AD8-4A5D-A517-F3063558B623Q42695192-DE66D4F4-B5AE-42EB-A539-22DC874A997EQ51149352-A1266890-34BC-47C9-8FD0-6732D435CDD8Q53833060-D3054274-CB55-4F37-B624-4E97E0DD39B1Q54974811-95435E42-34E2-4602-820D-71AA4485A570Q57171033-8DA59F7A-D943-42A7-95D1-DA1319160C45Q58780145-75A9FD78-BF44-4544-B60D-72321857DE73
P2860
Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Proton pump inhibitors and ris ...... ence and clinical implications
@ast
Proton pump inhibitors and ris ...... ence and clinical implications
@en
type
label
Proton pump inhibitors and ris ...... ence and clinical implications
@ast
Proton pump inhibitors and ris ...... ence and clinical implications
@en
prefLabel
Proton pump inhibitors and ris ...... ence and clinical implications
@ast
Proton pump inhibitors and ris ...... ence and clinical implications
@en
P2860
P356
P1476
Proton pump inhibitors and ris ...... ence and clinical implications
@en
P2093
Joel J Heidelbaugh
P2860
P304
P356
10.1177/2042098613482484
P577
2013-06-01T00:00:00Z